EGAPP|Evaluation of Genomic Applications in Practice and Prevention|Home

The EGAPP Working Group was established in 2005 to support the development of a systematic process for assessing the available evidence regarding the validity and utility of rapidly emerging genetic tests for clinical practice. This independent, multidisciplinary panel prioritizes and selects tests, reviews CDC-commissioned evidence reports and other contextual factors, highlights critical knowledge gaps, and provides guidance on appropriate use of genetic tests in specific clinical scenarios.

full-text:
EGAPP|Evaluation of Genomic Applications in Practice and Prevention|Home


EGAPP Working Group Recommendations

# Depression: Testing for cytochrome P450 polymorphisms in adults…
EGAPP|Recommendations|Depression


Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer?
EGAPP|Recommendations|Colorectal Cancer


Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives
EGAPP|Recommendations|Lynch


EGAPP|Working Group|Recommendations